Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Liquid Biopsy 2024: Technologies & Applications

Liquid Biopsy 2024: Technologies & Applications



Conference Chairman

Sunitha Nagrath

Sunitha Nagrath
Professor of Chemical Engineering and Biomedical Engineering, University of Michigan-Ann Arbor

Keynote Speakers


Daniel Hayes
Stuart B. Padnos Professor of Breast Cancer Research, University of Michigan Rogel Cancer Center


Sunitha Nagrath
Professor of Chemical Engineering and Biomedical Engineering, University of Michigan-Ann Arbor


Ian Papautsky
Richard and Loan Hill Professor of Bioengineering, Co-Director, NSF Center for Advanced Design & Manufacturing of Integrated Microfluidics, University of Illinois at Chicago

Overview

SelectBIO Liquid Biopsies 2024 focuses primarily on biofluid-based molecular biomarkers, such as circulating tumor DNA (ctDNA), Extracellular Vesicles (Exosomes) as well as circulating tumor cells (CTCs), and protein-based circulating biomarkers.  There is much interest in the potential of ctDNA for developing biological fluid-based biopsies (such as using plasma, urine, or other biofluids) and the presenters in this track bring together the most up-to-date information and current state-of-the-field.

The conference further explores the potential of various minimally-invasive circulating biomarker classes, such as circulating-free DNA (cfDNA), CTCs, and Extracellular Vesicles (EVs), for development of novel diagnostics for early disease screening, patient monitoring and minimal residual disease detection.

This conference is held concurrently with the Innovations in Microfluidics 2024 Conference enabling delegates full access to the scientific presentations in both conferences, co-located exhibit hall, and extensive networking opportunities.

Professor Sunitha Nagrath, Professor at the University of Michigan-Ann Arbor is serving as Conference Chairperson of Liquid Biopsies 2024 Conference

Agenda Topics

  • Circulating Tumor Cells (CTCs): Potential for Development of Liquid Biopsies
  • Circulating Tumor DNA (ctDNA) and Exosomes/EVs: Potential for Development of Liquid Biopsies
    • Emerging Technologies and Emerging Companies Showcase
    • Technology Platforms
  • Extracellular Nucleic Acids in the Circulation: Circulating Free DNA, Extracellular RNAs and Circulating microRNAs/Long Non-Coding RNAs
  • Microfluidics Platforms for Diagnostics Development

Sponsorship and Exhibition Opportunities

Jeff Fan, Exhibition Manager
jeff@selectbioconferences.com
+1-510-857-4865


Corporate SponsorsWeb SponsorsOffical Journal PartnerNetworking
Drug Discovery WorldU-Networks